Myofibrillar adenosine triphosphatase activity in congestive heart failure

¹ Department of Physiology, University of Illinois College of Medicine, Chicago, Illinois

Myofibrillar adenosine triphosphatase (ATPase) activity from seven failing and nine control hearts was studied. The failing hearts came from patients with a clinical and pathological diagnosis of congestive heart failure following benign essential hypertension. Normal hearts were obtained following traumatic death in otherwise normal subjects with no evidence of pathology. As the MgCl₂ concentration was increased, the myofibrillar ATPase from the failing hearts exhibited a significantly lower rise in activity than that from the normal hearts. Increasing the substrate concentration to 5 mm adenosine triphosphate (ATP) increased the myofibrillar ATPase activity to an optimum of .95 µm/mg/15 min in the normal group and .69/µm/ mg/15 min in the failing group. Further increases in substrate concentration decreased the ATPase activity in both groups. It was concluded that myofibrils from a heart in congestive failure following benign essential hypertension hydrolyze ATP at a slower rate than those from normal hearts. Since myofibrillar ATPase activity and tension development go hand in hand, the decrease in ATPase activity in the failing heart may account for its inability to meet the work load imposed upon it. Thus these experiments offer evidence that a lesion in congestive heart failure may reside in the contractile protein itself.

This article has been cited by other articles:

				A. M. Katz The "Modern" View of Heart Failure: How Did We Get Here? Circ Heart Fail, May 1, 2008; 1(1): 63 - 71. [Full Text] [PDF]

				N. Hamdani, V. Kooij, S. van Dijk, D. Merkus, W. J. Paulus, C. d. Remedios, D. J. Duncker, G. J.M. Stienen, and J. van der Velden Sarcomeric dysfunction in heart failure Cardiovasc Res, March 1, 2008; 77(4): 649 - 658. [Abstract] [Full Text] [PDF]

				M. C. G. Daniels, T. Naya, V. L. M. Rundell, and P. P. de Tombe Development of contractile dysfunction in rat heart failure: hierarchy of cellular events Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R284 - R292. [Abstract] [Full Text] [PDF]

				T. Noguchi, M. Hunlich, P. C. Camp, K. J. Begin, M. El-Zaru, R. Patten, B. J. Leavitt, F. P. Ittleman, N. R. Alpert, M. M. LeWinter, et al. Thin Filament-Based Modulation of Contractile Performance in Human Heart Failure Circulation, August 24, 2004; 110(8): 982 - 987. [Abstract] [Full Text] [PDF]

				R. J. Henning and Y. Li Cocaine Produces Cardiac Hypertrophy by Protein Kinase C Dependent Mechanisms Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 149 - 160. [Abstract] [PDF]

				T. Noguchi, Y. Kihara, K. J. Begin, J. A. Gorga, K. A. Palmiter, M. M. LeWinter, and P. VanBuren Altered Myocardial Thin-Filament Function in the Failing Dahl Salt-Sensitive Rat Heart: Amelioration by Endothelin Blockade Circulation, February 4, 2003; 107(4): 630 - 635. [Abstract] [Full Text] [PDF]

				N. R. Alpert, L. A. Mulieri, and D. Warshaw The failing human heart Cardiovasc Res, April 1, 2002; 54(1): 1 - 10. [Full Text] [PDF]

				J. N Peterson, R. Nassar, P. A W Anderson, and N. R Alpert Altered cross-bridge characteristics following haemodynamic overload in rabbit hearts expressing V3 myosin J. Physiol., October 15, 2001; 536(2): 569 - 582. [Abstract] [Full Text] [PDF]

				G. Hasenfuss Animal models of human cardiovascular disease, heart failure and hypertrophy Cardiovasc Res, July 1, 1998; 39(1): 60 - 76. [Abstract] [Full Text] [PDF]

				J van der Velden, A F M Moorman, and G J M Stienen Age-dependent changes in myosin composition correlate with enhanced economy of contraction in guinea-pig hearts J. Physiol., March 1, 1998; 507(2): 497 - 510. [Abstract] [Full Text] [PDF]

				P. P de Tombe Altered contractile function in heart failure Cardiovasc Res, February 1, 1998; 37(2): 367 - 380. [Abstract] [Full Text] [PDF]